Clinical Trial Update: Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study in healthy adults assessing the pharmacokinetics of Besifovir has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Besifovir (besifovir)

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED